2022 Recap: Your Favorite Alira Health Publications

Reports and White Papers

The 2022 MedTech Contract Manufacturing Report

2021 was a remarkable year for the global medical device industry—just as healthcare systems were learning to cope with the enduring effects of the COVID-19 pandemic, ramping up procedures and product demand, device manufacturers were hit by the most severe supply chain crisis in decades. Our report investigates how trends and the current environment will impact the industry. | Download the report

A Robotic-Assisted Surgery (RAS) Review: Clinical Landscape, Commercial Arena, and Future Outlook

One of our most popular reports for two years running! Created in collaboration with Hunniwell Ventures and MassMEDIC, this report examines adoption dynamics today—technologies, business models, stakeholders, decision criteria, funding and more—as well as what’s changing to drive this fast-growing market. | Download the report

Relative Weight of the Variables Evaluated Through the Therapeutic Positioning Reports in the Pricing and Reimbursement of Oncological and Oncohematology Medicines in Spain

Decisions for new drugs in Spain are based on regulation LGURM RD 1/2015 and the clinical evidence, economic value, and positioning of each new drug in relation to the Therapeutic Positioning Report (TPR). This white paper explores how despite this clear pricing & reimbursement (P&R) framework, the weight of each criterion on P&R decisions is not transparent. Only available in Spanish | Download the white paper

Articles

How—and Why—the Role of Clinical Data Manager is Changing

Clinical trials are becoming increasingly complex—new data collection technologies, data visualization tools, and the COVID-19 pandemic have all impacted the way trials are conducted. We spoke to Monica Pimazzoni, Director of Clinical Data Management of CROS NT, an Alira Health company, about how the role of data manager continues to evolve. | Read the article

Patient Advocacy and Digital Transformation: Why and How

Patient stories are powerful advocacy tools and combined with advanced technology helps advocacy groups provide better insights to drive improved care for patients and their caregivers. This three-part, on-demand training explores how technology can better catalyze patient outcomes. | Start the training

Successful Patient Advisory Boards: What Sponsors Need to Know

Patient Advisory Boards (PABs) allow sponsor companies to capture actionable patient feedback that can guide all stages of development and project prioritization, as well as improve research outcomes and de-risk early science. With patient engagement increasingly essential for successful commercialization, sponsors can leverage PABs to address many lifecycle challenges at once. | Read the article

Webinars and Expert Panels

Regulatory Strategy for Registering Rare Disease Products in the EU

Approximately 30 million people living in the EU suffer from a rare disease and rely on the Orphan Drug Regulation 141/2000 to bring appropriate medications to market. In 2021, the European Commission proposed amendments to the regulation. We explore what the current regulations and potential changes mean for orphan drug developers. | Watch the replay

Exclusive MedTech Series: Expanding Beyond APAC

Created in partnership with APACMed, this free, on-demand webinar series discusses the strategies, challenges, and best practices of entering new markets and scaling beyond the Asia Pacific for MedTech companies. | Watch the replay

Panel: Patient Advisory Boards in Clinical Research: Why and How

Watch the recording of this unique roundtable discussion around best practices for planning, setting up, and managing your Patient Advisory Board (PAB) alongside the leading industry experts. | Watch the replay